ArticleBMC health services research2025
Rideshare services for transportation assistance in gynecologic oncology: a quality improvement study.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Patient and Caregiver Reported Barriers to Cancer Clinical Trial Participation: A Scoping Review.Cancer reports (Hoboken, N.J.) · 2026Article
- Disparities in utilization of high-volume thyroid surgeons for Graves disease: a statewide analysis.Journal of the Endocrine Society · 2026Article
- Enhancing Healthcare Access for Older Adults through Innovative Mobility Solutions Leveraging Public Assets.JMA journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTransportation barriers can lead to delays in care and suboptimal treatment. Our objective was to assess the utilization of a novel transportation pilot intervention in gynecologic oncology.
methodsSince May 2022, we have provided donor-funded transportation to patients receiving gynecologic cancer treatment at 5 University of Pennsylvania practices. Patients are screened for transportation barriers at first visit and re-screened during care. Patients who screen positive are referred to the intervention, a HIPAA-compliant ride-sharing service. There are no income or insurance restrictions; distance was limited to 25 miles. We report descriptive statistics on ride completion, distance traveled, and cost.
resultsIn the 15-month pilot, 133 of 4,376 patients (3%) screened positive, and 48 (1%) patients received rides. Of 85 patients who screened positive, but did not receive ride-sharing, 43 (51%) had transportation assistance through their insurance, 12 (14%) lived more than 25 miles away, and the remainder (30; 35%) identified alternative transportation. Patients who received transportation assistance were more likely to be older, self-identify as a race other than white, have Medicare or Medicaid insurance, and have a higher ECOG score than the overall patient population. Eight patients received a single ride, and the rest (n = 40) received multiple rides (range 2-30) for total of 417 rides. The mean time via ride-sharing was 19.5 min shorter than public transportation, and mean cost of a one-way trip was $25.75 (range $13.83-129.91).
conclusionA rideshare service served a socially-vulnerable population and reduced commute times to oncology visits, which may contribute to more equitable access to cancer care. Further research on clinical outcomes is needed to understand the impact of transportation assistance on equitable cancer care delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.